Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies on
aspartate aminotransferase
(GOT) and L-alanine aminotransferase (GPT) of Paramphistomum explanatum have shown that GPT activity has more than twice the activity of GOT. The effect os some--SH reagents like
cadmium
, mercury, silver and iodoacetamide revealed that both enzymes were inhibited except that GOT was insensitive to
cadmium
ions. GPT was found to be much more sensitive to--SH reagents than GOT. There was unusual reaction to the two thiols used, cysteine and mercaptoethanol. Cysteine inhibited both the enzymes and mercaptoethanol activated GPT and inhibited GOT. Thiols in combination with iodoacetamide showed that the strong inhibitory effect of cysteine on both enzymes was reduced by iodoacetamide, but with mercaptoethanol the inhibitory effect on GOT was greater than when either of them was used alone, while GPT the effect of either counteracted each other. EDTA activated both enzymes and partially protected mercury inhibition of both enzymes and silver inhibition GOT only. It provided no protection against silver inhibition of GPT but complete protection of GPT against total inhibition by
cadmium
ions.
...
PMID:Effect of some--SH and other reagents on aspartate aminotransferase and L-alanine aminotransferase of Paramphistomum explanatum Fischoeder, 1901. 41 89
The comparative renal toxicity of rats after injection of
cadmium
(Cd) and zinc (Zn)-metallothioneins (MTs) with different Cd/Zn ratios at the same dose of 200 micrograms MT-bound Cd/kg was studied. From determination of the urinary excretion of protein,
aspartate aminotransferase
(
AST
) and glucose, which are indices of Cd-induced renal damage, the extent of the renal toxicity of the MTs used here was in the order (1 Cd/0Zn)-MT = (2Cd/1Zn)-MT greater than (1Cd/2Zn)-MT greater than (1Cd/6Zn)-MT. The characterization of Cd, Zn and Cu in the urine after injection of MTs was examined using a Sephadex G-75 column. (1Cd/0Zn)-MT injection showed that Cd was present mainly in lower-molecular-weight fractions, with only small amounts of Cd in the MT fraction. Upon injection of other MTs, Cd was present mainly in the MT fraction and increased with decreasing Cd/Zn ratio. Zn was present mainly in lower-molecular-weight fractions and Cu mainly in the MT fraction, indicating the replacement of MT-bound Zn by Cu. The cumulative urinary excretion of Cd during 12 days after injection of MTs decreased with increasing Cd/Zn ratio. The Cd content of the kidney and liver increased with increasing Cd/Zn ratio. The results of this study indicate that in rats injected with MTs with different Cd/Zn ratios, the renal uptake of Cd increases with increasing Cd/Zn ratio, resulting in more severe renal damage.
...
PMID:Comparative renal toxicity of metallothioneins with different cadmium/zinc ratios in rats. 201 79
Lipoate (thioctic acid) is presently used in therapy of a variety of diseases such as liver and neurological disorders. However, nothing is known about the efficacy of lipoate and its reduced form dihydrolipoate in acute
cadmium
(
Cd2+
) toxicity which involves severe liver disturbances. Therefore, we investigated the effects of these redox compounds on Cd2(+)-induced injuries in isolated rat hepatocytes. The cells were coincubated with 150 microM
Cd2+
and either 1.5-6.0 mM lipoate or 17-89 microM dihydrolipoate for up to 90 min and
Cd2+
uptake as well as viability criteria were monitored. Both exposure regimens diminished
Cd2+
uptake in correspondence to time and concentration. They also ameliorated Cd2(+)-induced cell deterioration as reflected by the decrease in Cd2(+)-induced membrane damage (leakage of
aspartate aminotransferase
), by the lessening of the Cd2(+)-stimulated lipid peroxidation (TBA-reactants) and by the increase in Cd2(+)-depleted cellular glutathione (GSH + 2 GSSG). Half-maximal protection was achieved at molar ratios of 9.9 to 19 (lipoate vs.
Cd2+
) and 0.25 to 0.74 (dihydrolipoate vs.
Cd2+
), indicating a 19.5 to 50.6 lower protective efficacy of lipoate as compared to dihydrolipoate. Lipoate induced an increase in extracellular acid-soluble thiols different from glutathione. It is suggested that dihydrolipoate primarily protects cells by extracellular chelation of
Cd2+
, whereas intracellular reduction of lipoate to the dihydro-compound followed by complexation of both intra- and extracellular
Cd2+
contributes to the amelioration provided by lipoate.
...
PMID:Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium2+ toxicity in isolated hepatocytes. 211 57
The effect of N-benzyl-D-glucamine dithiocarbamate (BGD) on the renal toxicity induced by acute exposure to
cadmium
-metallothionein (Cd-MT) in rats was studied. Rats were injected intraperitoneally with BGD (400 mumol/kg) 6, 12, or 24 h after intraperitoneal injection of Cd-MT (1.78 mumol Cd as Cd-MT/kg) and thereafter they received three injections of BGD (400 mumol/kg) daily for 3 days. Urinary protein concentration and
aspartate aminotransferase
(
AST
) activity significantly increased 1 day after Cd-MT treatment and decreased to control levels at 9 days after the treatment. Urinary excretion of glucose and amino acids rose gradually reaching maximum levels 5 days after Cd-MT treatment and returned to the control levels at 9 days. BGD injection significantly reduced the increases in the urinary excretion of protein,
AST
, glucose and amino acid, which were produced by Cd-MT treatment. Significant increases in urine volume were observed after Cd-MT treatment. BGD injection inhibited the increase in urine volume caused by Cd-MT treatment. A long time interval (12 and 24 h) between the administrations of Cd-MT and BGD resulted in a decreased protective effect of BGD against Cd-MT-induced renal damage. Following Cd-MT injection, the major route of excretion of
cadmium
(Cd) was via the urine and the kidney was the major site of accumulation of Cd. BGD injection remarkably increased the urinary excretion of Cd, resulting in a significant reduction in the kidney Cd concentration. The results of this study indicate that BGD injection is effective in decreasing the Cd concentration in the kidney, resulting in the protective effect on Cd-MT-induced renal damage.
...
PMID:Effect of N-benzyl-D-glucamine dithiocarbamate on renal toxicity induced by cadmium-metallothionein in rats. 235 Feb 40
The suitability of DL-alpha-lipoic acid (LA) to serve as an antidote in
cadmium
(Cd) toxicity in rat hepatocytes was investigated. Isolated hepatocytes were exposed to 200 and 450 microM Cd in the presence of 0.2, 1.0 and 5.0 mM LA, respectively. After 30 min of incubation various criteria of cell viability were monitored. Lipoic acid markedly diminished Cd uptake. Concomitantly, Cd-induced membrane injury, as reflected by the leakage of
aspartate aminotransferase
and sorbitol dehydrogenase (SDH) was decreased. Moreover, LA protected against intracellular toxic responses to Cd, such as a decrease in cellular SDH activity, a decrease in cellular acid soluble thiols, especially in total glutathione, a decrease in cellular urea and an increase in thiobarbituric acid (TBA) reactants, as a measure of lipid peroxidation. Most protective effects were seen in hepatocytes challenged with the lower Cd concentration and coincubated with 5 mM LA. In contrast, at 450 microM Cd even the highest LA concentration applied either did only reverse Cd-effects incompletely (SDH-response, TBA-reactants) or did not protect at all (Cd uptake, enzyme leakage, loss of glutathione). The data indicate that DL-alpha-lipoic acid serves as a protective tool against Cd-induced membrane damage and cell dysfunction in hepatocytes. This stands as long as Cd exposure is low enough to permit interaction with LA prior to interaction with cell structures.
...
PMID:Protective effects of DL-alpha-lipoic acid on cadmium-induced deterioration of rat hepatocytes. 250 68
Studies were carried out on the effect of various
cadmium
doses, which were given to growing rats in diet. A 42-day biological experiment was carried out on male growing Wistar rats. The animals divided into groups were given diets containing
cadmium
in amounts of 50, 100 and 200 ppm and diet with no adding
cadmium
. The diets contained 20% of protein in equal amounts from wheat gluten and casein. It was demonstrated that
cadmium
had a significant influence on diet intake and growth of rats. The absorption from diets containing 50, 100 and 200 ppm of
cadmium
was about 30 to 48%. The more
cadmium
was absorbed, the most was in blood and rat liver. Anaemia was noted in animals, which were given diets with
cadmium
. Rats had a low level of haematocrit and haemoglobin in plasma. It was shown that
cadmium
intake caused a significant decrease in plasma albumin concentration and increase of plasma alanine aminotransferase and
aspartate aminotransferase
activity.
...
PMID:[Effect of various cadmium doses in the diet on the body of growing rats]. 263 83
The purpose of the study was assessment of the effect of an environment contaminated with heavy metals on the activity of certain enzymes of mixed saliva. The activity was determined of total acid phosphatase and phosphatase resistant to tartrate and formaldehyde, alkaline phosphatase, alanine and
aspartate aminotransferase
, and alpha-amylase. The studied material comprised 110 saliva samples obtained from three groups of children aged 8 years. Group I of 21 children lived in Szopienice, group II of 30 children lived in Miasteczko Slaskie. In both these localities the children were exposed to mean daily concentrations, above the permitted ones, mainly of lead compounds, in lower degree to
cadmium
and zinc compounds. Environment contamination in Szopienice was greater than in Miasteczko Slaskie. Group III of 59 children living in Lubowice served as controls. In that town the permissible concentrations of these compounds were not exceeded. Statistical analysis of these results showed that the activity of total acid phosphatase in groups I and II, that is in the contaminated areas, was highly significantly greater than in the control group. The activity of alkaline phosphatase was raised only in the saliva in group I. No differences were found in the activity of alpha-amylase and aminotransferases.
...
PMID:[Activity of certain salivary enzymes in school children exposed to excessive concentrations of lead and cadmium]. 264 Jun 43
The effect of
cadmium
administration on female Bufo regularis was studied. The median lethal doses were 22, 18, 15 and 6.2 mg
Cd2+
/kg after 24, 48, 72 and 96 hr respectively. After a single intramuscular injection of 6.2 mg
Cd2+
/kg (representing 96-hr LD50), the results indicated that
Cd2+
causes severe physiological abnormalities to this experimental animal. The serums alanine aminotransferase (AlAt),
aspartate aminotransferase
(AAt), alkaline phosphatase (AlP) and lactic dehydrogenase (LDH) were elevated while the calcium serum was not influenced by
Cd2+
throughout the experimental period. On the other hand, phosphorus, total protein and total bilirubin were increased. EDTA treatment (0.2 mmole/kg) protected female toads from mortality up to 20 mg
Cd2+
/kg. It overcame the physiological alterations that were caused by the
Cd2+
injection. This may be due to the fact that
Cd2+
is bound to EDTA in a strong complex which is readily excreted via the kidneys.
...
PMID:Toxicity of cadmium administration to the toad and the treatment of its poisoning with EDTA. 287 99
The administration of sodium N-methyl-N-dithiocarboxy-D-glucamine (NaG) at 500 mg/kg, i.p., or sodium calcium diethylenetriaminepentaacetic acid (DTPA) at 632.5 mg/kg, i.p., reduces the serum enzyme levels characteristic of hepatic damage following the intravenous administration of
cadmium
chloride (3.5 mg CdCl2.2.5H2O/kg). Some effect on serum enzyme levels was found even when the interval between administration of
cadmium
chloride and that of the antagonist was as great as 4 h. The enzymes examined included
aspartate aminotransferase
(
AST
), gamma-glutamyl transpeptidase (GGT), alanine aminotransferase (SGPT), and alkaline phosphatase (AP). A histopathological examination of the livers of such animals also reveals the presence of a significant protective action.
...
PMID:Chelating-agent suppression of cadmium-induced hepatotoxicity. 289 Jul 68
The effect of N-benzyl-D-glucamine dithiocarbamate (BGD) on the renal toxicity produced by subacute exposure to
cadmium
in rats was studied. Rats were injected sc with CdCl2 (1.5 mg Cd/kg) daily for 26 days and thereafter they received 13 injections of BGD (400 mumol/kg) every other day. Urinary protein concentration and
AST
activity significantly increased after 20 days of
cadmium
treatment. The pattern of the increase in the urinary excretion of
cadmium
after
cadmium
treatment was consistent with that in the urinary excretion of protein and
AST
. Urinary excretion of amino acid increased gradually after the cessation of
cadmium
treatment. BGD treatment significantly decreased the urinary excretion of protein,
aspartate aminotransferase
(
AST
), and amino acid. Plasma
AST
activity was elevated 8 days after the beginning of
cadmium
treatment, indicating that the hepatic damage occurred prior to the renal damage. In addition, the microscopic examination of renal tissue from
cadmium
-treated rats revealed the necrosis of the proximal tubular cells. The
cadmium
concentrations in liver and kidney were significantly decreased by BGD treatment. The results of this study indicate that BGD treatment is effective in decreasing the
cadmium
concentrations in liver and kidney, resulting in the therapeutic effect on the
cadmium
-induced renal damage.
...
PMID:Effect of N-benzyl-D-glucamine dithiocarbamate on the renal toxicity produced by subacute exposure to cadmium in rats. 292 20
1
2
3
4
5
6
7
8
9
10
Next >>